close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elicio Therapeutics, Inc. - Common Stock (NQ:ELTX)

1.900 +0.080 (+4.40%)
Delayed Quote Updated: 1:22 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 178,154
Open 1.820
Bid (Size) 1.890 (800)
Ask (Size) 1.900 (200)
Prev. Close 1.820
Today's Range 1.820 - 1.920
52wk Range 1.705 - 16.00
Shares Outstanding 29,798,399
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
From Elicio Therapeutics Inc.
Via GlobeNewswire

Performance

YTD
-76.4%
-76.4%
1 Month
-29.6%
-29.6%
3 Month
-63.0%
-63.0%
6 Month
-82.2%
-82.2%
1 Year
-82.6%
-82.6%

More News

Read More
News headline image
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma
From Elicio Therapeutics Inc.
Via GlobeNewswire
Here are the top movers in Wednesday's session. ↗
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc. - ELTX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering
From Elicio Therapeutics Inc.
Via GlobeNewswire
Here are the top movers in Thursday's session. ↗
Via Chartmill
Top movers in Thursday's session ↗
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc. - ELTX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes
From Elicio Therapeutics Inc.
Via GlobeNewswire
News headline image
ELTX Investors Have Opportunity to Join Elicio Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc. - ELTX
From Pomerantz LLP
Via GlobeNewswire
These stocks have an unusual volume in today's session ↗
Via Chartmill
Which stocks have an unusual volume on Thursday? ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
Which stocks are moving after the closing bell on Wednesday? ↗
Via Chartmill
Top movers in Wednesday's session ↗
Via Chartmill
News headline image
Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer
From Elicio Therapeutics Inc.
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Monday's session: top gainers and losers ↗
Via Chartmill

Frequently Asked Questions

Is Elicio Therapeutics, Inc. - Common Stock publicly traded?
Yes, Elicio Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Elicio Therapeutics, Inc. - Common Stock trade on?
Elicio Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Elicio Therapeutics, Inc. - Common Stock?
The ticker symbol for Elicio Therapeutics, Inc. - Common Stock is ELTX on the Nasdaq Stock Market
What is the current price of Elicio Therapeutics, Inc. - Common Stock?
The current price of Elicio Therapeutics, Inc. - Common Stock is 1.900
When was Elicio Therapeutics, Inc. - Common Stock last traded?
The last trade of Elicio Therapeutics, Inc. - Common Stock was at 10/01/26 01:22 PM ET
What is the market capitalization of Elicio Therapeutics, Inc. - Common Stock?
The market capitalization of Elicio Therapeutics, Inc. - Common Stock is 56.62M
How many shares of Elicio Therapeutics, Inc. - Common Stock are outstanding?
Elicio Therapeutics, Inc. - Common Stock has 57M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.